UNSPSC 51343705: Rilpivirine hydrochloride

This classification denotes a reverse transcriptase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 212WAX8KDD. European Medicines Agency schedules Rilpivirine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31460. Rilpivirine hydrochloride generally arises in the molecular formula C22H18N6.CLH. The term 'rilpivirine hydrochloride' is a United States Adopted Name designation.

Most nations, for tariff and trade purposes, schedule rilpivirine hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, RILPIVIRINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC1CC(CC(C1NC2CCNC(N2)NC3CCC(CC3)C#N)C)/C=C/C#N.CL.

UNSPSC 51343705 Rilpivirine hydrochloride is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The source contains four recent opportunities spanning naloxone and drug deactivation systems, direct-to-manufacturer pharmacy programs, general medical and first aid supplies, and generic multi-source pharmaceuticals and OTC products — none of which are rilpivirine hydrochloride or antiretroviral therapies. The code's nominal scope (a specific antiretroviral pharmaceutical) and the work actually being solicited diverge significantly; state and local buyers are pursuing broad-spectrum procurement of emergency medical supplies, pharmacy benefit program restructuring, and generic pharmaceutical supply agreements rather than procurement of this particular drug formulation.

The recent opportunities show activity across Florida (Seminole County), Texas (HHS Commission), Minnesota (MMCAP cooperative purchasing), and Oregon (participating in MMCAP), with issuing bodies ranging from county health departments to state pharmacy agencies to municipal fire departments. Representative solicitations include Seminole County's IFB60459723LAS (naloxone and drug deactivation systems, due July 26, 2023), the City of Tampa's IFB 26P00145 (medical and first aid supplies for the Fire Department, due March 13, 2026, with an estimated contract value of $700,000.00 and a 5% SLBE bid discount), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (generic multi-source pharmaceuticals and OTC products, due March 26, 2026). The code shows little relevant recent activity; vendors pursuing state and local procurement under this UNSPSC should verify that opportunities are properly tagged before investing in pursuit strategy.